221 related articles for article (PubMed ID: 32158230)
1. Progression of Thyroid Carcinoma Is Promoted by the m6A Methyltransferase METTL3 Through Regulating m
Wang K; Jiang L; Zhang Y; Chen C
Onco Targets Ther; 2020; 13():1605-1612. PubMed ID: 32158230
[TBL] [Abstract][Full Text] [Related]
2. m6A methyltransferase METTL3 promotes the progression of prostate cancer via m6A-modified LEF1.
Ma XX; Cao ZG; Zhao SL
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3565-3571. PubMed ID: 32329830
[TBL] [Abstract][Full Text] [Related]
3. The m6A methyltransferase METTL3 aggravates the progression of nasopharyngeal carcinoma through inducing EMT by m6A-modified Snail mRNA.
Yu X; Zhao H; Cao Z
Minerva Med; 2022 Apr; 113(2):309-314. PubMed ID: 32512975
[TBL] [Abstract][Full Text] [Related]
4. The m6A methyltransferase METTL3 promotes the stemness and malignant progression of breast cancer by mediating m6A modification on SOX2.
Xie J; Ba J; Zhang M; Wan Y; Jin Z; Yao Y
J BUON; 2021; 26(2):444-449. PubMed ID: 34076991
[TBL] [Abstract][Full Text] [Related]
5. METTL3 promotes colorectal carcinoma progression by regulating the m6A-CRB3-Hippo axis.
Pan J; Liu F; Xiao X; Xu R; Dai L; Zhu M; Xu H; Xu Y; Zhao A; Zhou W; Dang Y; Ji G
J Exp Clin Cancer Res; 2022 Jan; 41(1):19. PubMed ID: 35012593
[TBL] [Abstract][Full Text] [Related]
6. The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.
Miao W; Chen J; Jia L; Ma J; Song D
Biochem Biophys Res Commun; 2019 Aug; 516(3):719-725. PubMed ID: 31253399
[TBL] [Abstract][Full Text] [Related]
7. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Ma Z; Li Q; Liu P; Dong W; Zuo Y
Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
[TBL] [Abstract][Full Text] [Related]
8. IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation.
Cao P; Wu Y; Sun D; Zhang W; Qiu J; Tang Z; Xue X; Qin L
Cancer Med; 2023 Feb; 12(4):4405-4420. PubMed ID: 35908253
[TBL] [Abstract][Full Text] [Related]
9. m
Xu L; Li Q; Wang Y; Wang L; Guo Y; Yang R; Zhao N; Ge N; Wang Y; Guo C
Am J Cancer Res; 2021; 11(11):5282-5298. PubMed ID: 34873461
[TBL] [Abstract][Full Text] [Related]
10. The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF.
Cheng Y; Fu Y; Wang Y; Wang J
Front Genet; 2020; 11():955. PubMed ID: 33061938
[TBL] [Abstract][Full Text] [Related]
11. METTL3 facilitates the progression of hepatocellular carcinoma by modulating the m6A level of USP7.
Li Y; Cheng X; Chen Y; Zhou T; Li D; Zheng WV
Am J Transl Res; 2021; 13(12):13423-13437. PubMed ID: 35035685
[TBL] [Abstract][Full Text] [Related]
12. METTL3 modulates m6A modification of CDC25B and promotes head and neck squamous cell carcinoma malignant progression.
Guo YQ; Wang Q; Wang JG; Gu YJ; Song PP; Wang SY; Qian XY; Gao X
Exp Hematol Oncol; 2022 Mar; 11(1):14. PubMed ID: 35287752
[TBL] [Abstract][Full Text] [Related]
13. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
[TBL] [Abstract][Full Text] [Related]
14. METTL3 facilitates tumor progression via an m
Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
[TBL] [Abstract][Full Text] [Related]
16. N6-Methyladenosine Methyltransferase METTL3 Promotes Angiogenesis and Atherosclerosis by Upregulating the JAK2/STAT3 Pathway via m6A Reader IGF2BP1.
Dong G; Yu J; Shan G; Su L; Yu N; Yang S
Front Cell Dev Biol; 2021; 9():731810. PubMed ID: 34950654
[TBL] [Abstract][Full Text] [Related]
17. Methyltransferase-like 3 Aggravates HCC Development via Mediating N6-Methyladenosine of Ubiquitin-Specific Protease 7.
Yuan D; Chen J; Hao Q; Zhang P; Chen Z
J Oncol; 2022; 2022():6167832. PubMed ID: 35571490
[TBL] [Abstract][Full Text] [Related]
18.
Huang S; Chen B; Qiu P; Yan Z; Liang Z; Luo K; Huang B; Jiang H
Transl Cancer Res; 2023 Jun; 12(6):1588-1601. PubMed ID: 37434681
[TBL] [Abstract][Full Text] [Related]
19. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
[TBL] [Abstract][Full Text] [Related]
20. The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.
Zhao C; Ling X; Xia Y; Yan B; Guan Q
Cancer Cell Int; 2021 Aug; 21(1):441. PubMed ID: 34419065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]